Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Umeclidinium/vilanterol
2. Vilanterol / Umeclidinium
3. Umeclidinium And Vilanterol
4. Umeclidinium Bromide / Vilanterol
5. Umeclidinium Bromide And Vilanterol
6. Gsk 573719
7. Umeclidinium Bromide Mixture With Vilanterol
8. S900006130
| Molecular Weight | 994.9 g/mol |
|---|---|
| Molecular Formula | C53H67BrCl2N2O7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 24 |
| Exact Mass | 992.35087 g/mol |
| Monoisotopic Mass | 992.35087 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Anoro ellipta |
| PubMed Health | Umeclidinium/Vilanterol (By breathing) |
| Drug Classes | Mucolytic, Respiratory Agent |
| Active Ingredient | vilanterol trifenatate; Umeclidinium bromide |
| Dosage Form | Powder |
| Route | Inhalation |
| Strength | eq 0.025mg base/inh; eq 0.0625mg base/inh |
| Market Status | Prescription |
| Company | Glaxosmithkline |
| 2 of 2 | |
|---|---|
| Drug Name | Anoro ellipta |
| PubMed Health | Umeclidinium/Vilanterol (By breathing) |
| Drug Classes | Mucolytic, Respiratory Agent |
| Active Ingredient | vilanterol trifenatate; Umeclidinium bromide |
| Dosage Form | Powder |
| Route | Inhalation |
| Strength | eq 0.025mg base/inh; eq 0.0625mg base/inh |
| Market Status | Prescription |
| Company | Glaxosmithkline |
Digital Content 
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A Ellipta manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ellipta, including repackagers and relabelers. The FDA regulates Ellipta manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ellipta API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ellipta supplier is an individual or a company that provides Ellipta active pharmaceutical ingredient (API) or Ellipta finished formulations upon request. The Ellipta suppliers may include Ellipta API manufacturers, exporters, distributors and traders.
Ellipta Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ellipta GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ellipta GMP manufacturer or Ellipta GMP API supplier for your needs.
A Ellipta CoA (Certificate of Analysis) is a formal document that attests to Ellipta's compliance with Ellipta specifications and serves as a tool for batch-level quality control.
Ellipta CoA mostly includes findings from lab analyses of a specific batch. For each Ellipta CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ellipta may be tested according to a variety of international standards, such as European Pharmacopoeia (Ellipta EP), Ellipta JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ellipta USP).
LOOKING FOR A SUPPLIER?
